TLX007-CDx is a cold kit designed for the preparation of PSMA-targeted PET imaging for prostate cancer. It leverages ...

A new at-home saliva test could help identify men with a high risk of prostate cancer more accurately than blood tests, ...

Symptoms of prostate cancer may include needing to urinate more frequently; having to rush to the toilet; straining to ...

A shorter, higher-dose radiation treatment for prostate cancer is just as safe and effective as conventional radiotherapy, ...

Dr. Chandler Park sat down for an interview with CURE® to discuss the biggest takeaway from the 2025 ASCO GU Symposium in ...

A new at-home saliva test could easily help identify men with a high risk of prostate cancer more accurately than blood tests, leading to earlier diagnosis and more successful treatment. At present, ...

A groundbreaking treatment for prostate cancer now available in Virginia aims to improve patient outcomes while minimizing side effects associated with traditional surgeries and radiation therapies.

Men who experience acute adverse effects after radiation therapy for prostate cancer may be at higher risk for more serious ...

“Prostate-specific membrane antigen (PSMA) PET imaging can identify patients suitable for PSMA-targeted radioligand therapy such as lutetium-177-PSMA-617. This is crucial for mCRPC patients who have ...

Telix Pharmaceuticals Limited today announces that the United States Food and Drug Administration has approved its New Drug ...

Men who consistently avoid prostate cancer screening appointments face a disproportionately higher risk of dying from the disease, finds research identifying a new high-risk group.